Home About CDC Press Room Funding A-Z Index Centers, Institute & Offices Training & Employment Contact Us
CDC Centers for Disease Control and Prevention Home Page
_  
Search: 
 
Health & Safety TopicsPublications & ProductsData & StatisticsConferences & Events
_
Program Contents
bullet Topic Home
bullet About IDSR
bullet IDSR Partners
bullet Countries
bullet Focus areas
bullet Resources
bullet Contact
Quick Links

bullet IDSR lab meeting,
Atlanta, GA
September 2006
English PDF | French PDF
  bullet Progress with IDSR implementation
  bullet IDSR core indicators
 
Contact Info
Clifton Road NE, MS C-12
Atlanta, GA 30333
Phone: 1(404) 639-2416
Fax: 1(404) 639-3106
_
Integrated Disease Surveillance and Response

External Quality Assessment Programme in Africa

In July 2002, the National Health Laboratory Service (NHLS) of South Africa launched the External
Quality Assessment (EQA) Programme for national laboratories of Africa. The programme was established by the WHO Department of Communicable Disease Surveillance and Response (CSR) in Lyon, France for laboratory and epidemiology capacity development. The EQA programme aims to help participating laboratories assess their capabilities and guides WHO AFRO in developing activities targeted to address the laboratories’ needs.

Map showing African countries participating in External Quality Assessment Programme, July 2002 through January 2003

The EQA programme is organized by the NHLS, with participation from 38 testing laboratories in 29 African countries and nine WHO worldwide collaborating laboratories. The testing laboratories are either national public health referral laboratories or laboratories that are part of the Haemophilus influenzae Pediatric Bacterial Meningitis Surveillance Network (Hib PBM) for their country. The collaborating laboratories provide technical advice to NHLS in their specialty areas.

The programme focuses on standard laboratory confirmation of three epidemic-prone disease areas: bacterial diarrheal diseases, bacterial meningitis, and plague. NHLS develops and distributes surveys containing simulated clinical specimens and instruction packets to the testing and collaborating laboratories. The surveys are designed to assess laboratory confirmation abilities including antimicrobial susceptibility, and the activities that come before
and after testing, such as processing, communication, and documentation. The EQA programme completed its first year, with three shipments of surveys: in July and October 2002, and in January 2003. NHLS has analyzed the results of the first two shipments and is now completing analysis of the final one. WHO AFRO will establish a regional EQA advisory group to review the data and make recommendations.

Initially, the EQA programme will focus on maintaining the participation of laboratories and serve as an educational tool. Next year, WHO AFRO plans to expand participation by 10 or more national laboratories in the African region. The EQA programme in Africa could serve as a model for developing similar programs in other WHO regions in the future.

The WHO headquarters and CSR, Lyon, along with the CDC provide technical support to NHLS. The programme is sponsored by WHO CSR, Lyon with funding from the U.S. Agency for International Development. Contributing Editor: Bradford Kay, DrPH, MPH, MS - CSR WHO, Lyon

External Quality Assessment (EQA) Programme for the National Laboratories of Africa

Process diagram
1 Introductory information includes:
  1) purpose of the EQA programme,
  2) roles and responsibilities of organizing and participating laboratories,
  3) criteria used to assess survey results, 4) criteria for recognition of laboratory participation and good performance, and 5) contact information for organizing laboratory.
2 A consignment is a shipment of surveys to testing and collaborating laboratories
3 A survey contains simulated clinical specimens representing a bacterial diarrheal
disease or bacterial meningitis or plague. This survey also contains instructions
and a response form.
  Instructions include:
  1) description of the specimens and handling procedures,
  2) a report form with instructions and survey closing date, and
  3) clinical details and technical information about specimens.
4 A commentary contains an evaluation of the results submitted by the testing
laboratory and a summary of results of all laboratories for that survey. It also
contains background information about the specimens and tests expected
for laboratory confirmation.


 
 
Date: June 2, 2005
Content source: Coordinating Center for Infectious Diseases / Division of Bacterial and Mycotic Diseases
 
    Home   |   Policies and Regulations   |   Disclaimer   |   e-Government   |  FOIA   |  Contact Us  
Safer, Healthier People USA.govDHHS Department of Health
and Human Services
Centers for Disease Control and Prevention,1600 Clifton Rd, Atlanta, GA 30333, U.S.A
Tel: (404) 639-3311 / Public Inquiries: (404) 639-3534 / (800) 311-3435